[ccpw id="5"]

Home.forex news reportM&T Bank Earnings Preview: What to Expect

M&T Bank Earnings Preview: What to Expect

-


Buffalo, New York-based M&T Bank Corporation (MTB) operates as a bank holding company, which engages in the provision of retail and commercial banking, trust, wealth management, and investment services. With a market cap of $27.9 billion, M&T Bank operates through Commercial Bank, Retail Bank, and Institutional Services and Wealth Management segments.

MTB is set to announce its Q4 results before the markets open on Friday, Jan. 16. Ahead of the event, analysts expected MTB to deliver an EPS of $4.46, up 13.8% from $3.92 reported in the year-ago quarter. While the company has surpassed the Street’s bottom-line estimates thrice over the past four quarters, it has missed the projections on one other occasion.

For the full fiscal 2025, MTB is expected to deliver an EPS of $16.71, up 12.3% from $14.88 reported in fiscal 2024. Meanwhile, in fiscal 2026, its earnings are expected to further grow by 11.9% year-over-year to $18.70 per share.

www.barchart.com
www.barchart.com

MTB stock prices have gained 9.4% over the past 52 weeks, lagging behind the S&P 500 Index’s ($SPX) 15.4% surge and the Financial Services Select Sector SPDR Fund’s (XLF) 14.5% returns during the same time frame.

www.barchart.com
www.barchart.com

M&T Bank’s stock prices declined 3.5% in the trading session following the release of its mixed Q3 results on Oct. 16. Although the company observed a 4% decline in interest income compared to the year-ago quarter, it observed an even steeper 13% drop in interest expenses, leading to a notable 2% growth in net interest income (NII) reaching $1.6 billion. Further, MTB’s other non-interest income surged 24.1% year-over-year to $752 million. Overall, the company’s topline came in at $2.4 billion, up 8% year-over-year, missing the consensus estimates by a thin margin.

Meanwhile, MTB’s earnings increased by an impressive 19.4% year-over-year to $4.87, beating the consensus estimates by 10.7%. Following the initial dip, MTB stock prices maintained a positive momentum for two subsequent trading sessions.

Analysts remain optimistic on the stock’s prospects. MTB holds a consensus “Moderate Buy” rating among the 23 analysts covering the stock. That’s based on 11 “Strong Buys,” one “Moderate Buy,” 10 “Holds,” and one “Strong Sell.” Its mean price target of $220.48 suggests an 8.3% upside potential from current price levels.

On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

China’s pharmaceutical sector moves into the big leagues as a global innovation powerhouse

China is gaining a solid reputation as a pharmaceutical innovation hub, shifting from a copycat drug maker to one whose infrastructure...

BeOne Medicines names R&D chief Wang Lai as co-president to lead global expansion

BeOne Medicines, a global drug company that originated as a research and development (R&D) firm in Beijing, promoted Wang Lai to...

What You Need to Know Ahead of State Street’s Earnings Release

State Street Corporation (STT), headquartered in Boston, Massachusetts, provides a range of financial products and services to institutional investors worldwide. Valued...

Brazil commits to rapid energy roadmap deadline for key ministries

Stay informed with free updatesSimply sign up to the Climate change myFT Digest -- delivered directly to your inbox.Brazil has committed to a two-month...

Follow us

0FansLike
0FollowersFollow
0SubscribersSubscribe

Most Popular

spot_img